Shares of DarioHealth Corp. are up 29% in premarket trading Monday after the company said it had received FDA clearance for its blood glucose monitoring system to be used on Apple Inc. iPhone 7, 8, and X devices via the Lightning port on these phones. The monitor also works with a 3.5mm headphone jack. “With today’s news, DarioHealth plans to expand U.S. sales in the coming weeks,” the company said in a release. It’s been marketing its product for Samsung Electronics Co. Ltd.’s Galaxy S, Galaxy Note, and LG G phones since the fall. Dario Health shares were down 12.6% over the past year as of Friday’s close, compared with a 10% rise for the S&P 500 .
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News